Lamberink HJ, Otte WM, Blümcke I, Braun KPJ, European Epilepsy Brain Bank writing group, Study Group, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: A retrospective multicentre cohort study. Lancet Neurol 2020, 19: 748–757.

Ribierre T, Bacq A, Donneger F, Doladilhe M, Maletic M, Roussel D, et al. Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy. Nat Neurosci 2024, 27: 1125–1136.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iffland PH 2nd, Crino PB. Focal cortical dysplasia: Gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol 2017, 12: 547–571.

Article  CAS  PubMed  Google Scholar 

Møller RS, Weckhuysen S, Chipaux M, Marsan E, Taly V, Bebin EM, et al. Germline and somatic mutations in the mTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet 2016, 2: e118.

Article  PubMed  PubMed Central  Google Scholar 

Kato M, Kada A, Shiraishi H, Tohyama J, Nakagawa E, Takahashi Y, et al. Sirolimus for epileptic seizures associated with focal cortical dysplasia type II. Ann Clin Transl Neurol 2022, 9: 181–192.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsieh LS, Wen JH, Claycomb K, Huang Y, Harrsch FA, Naegele JR, et al. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement. Nat Commun 2016, 7: 11753.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 2020, 21: 183–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng J, Wang Y, Liu Y, Han S, Zhang Y, Luo Y, et al. cPKCγ deficiency exacerbates autophagy impairment and hyperphosphorylated tau buildup through the AMPK/mTOR pathway in mice with type 1 diabetes mellitus. Neurosci Bull 2022, 38: 1153–1169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 2015, 17: 1049–1061.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herranz N, Gallage S, Mellone M, Wuestefeld T, Klotz S, Hanley CJ, et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol 2015, 17: 1205–1217.

Article  CAS  PubMed  PubMed Central  Google Scholar